“Emerging Therapeutic Agents in the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma”. Canadian Hematology Today, vol. 1, no. 1, Mar. 2022, pp. 43–47, https://doi.org/10.58931/cht.2022.1110.